Interim Results

RNS Number : 7874Y
Pets At Home Group Plc
04 December 2014
 



 

FOR IMMEDIATE RELEASE, 4 DECEMBER 2014

Pets At Home Group Plc: Interim Financial Results FY15

Delivering on the strategic plan across all measures

Pets At Home Group Plc, the UK's leading specialist retailer of pet food, accessories, pet-related products and services, today announces its interim results for the 28 week period from 28th March to 9th October 2014.

H1 FY15 financial highlights

·     Total revenue growth of 10.2% to £381.5m

Merchandise revenues up 8.9% to £348.3m, comprised of Food revenues up 9.6% to £188.7m and Accessories revenues up 8.0% to £159.6m

Services revenues up 27.0% to £33.2m, reflecting both new openings and the growing revenue streams from our maturing vet practices and Groom Rooms

·     Like-for-like (LFL) sales growth 4.2%, driven by strength in Advanced Nutrition, Health & Hygiene, VIP Club, growth from our vet practices and Groom Rooms, and omnichannel

Merchandise LFL revenue growth of 3.7%

Services LFL revenue growth of 10.2%

·     Gross margin of 53.8%, +20bps on the prior year; reflecting Merchandise margin +7bps to 55.9% and strong Services margin expansion +546bps to 31.7%

·     Underlying EBITDA of £58.6m (+10.8%) and margin of 15.4%, expansion of 8bps on the prior year, despite £1.4m in additional Plc operating costs

·     Underlying free cashflow of £33.8m, conversion of 57.7% compared with prior year at 43.8%

·     Interim dividend of 1.8p per share

H1 FY15 Operational highlights

·     Added 8 stores net to the portfolio total of 385; including 10 new stores, one store closure in Knutsford, and a temporary closure of our Rugby store which will be relocated in H1 FY16

·     Opened 26 veterinary practices, bringing the total portfolio to 303

·     Opened 23 Groom Rooms, bringing the total portfolio to 152

·     VIP Club reached 2.6m members, up from 2.0m at the end of FY14

·     Wainwright's grew 54.8% to £20.5m, driven by launches of WW's Cat & Grain Free for dogs

·     Refreshed 30% of total SKUs, of which over a third are own brand or private label

·     Deliver To Store online offering now fully operational, which gives customers access to the extended omnichannel range of 10,800 SKUs for pickup in their local store

Outlook

The pet care market outlook remains positive. We continue to expect gross openings of around 25 stores, 60 veterinary practices and 50 Groom Room salons in FY15.

Management and the Board remain confident in the Group's prospects for the year and trading since the end of the half year period has been in line with our expectations.

 

Nick Wood, Chief Executive Officer, commented:

"We are pleased with our first half financial performance. We continue to deliver on our strategy to be the leading destination brand for pet lovers, with particularly strong performance from new growth areas including vets and groom rooms. Our passion for pets guides everything we do and it's a passion we share with our customers, with more than half a million joining our VIP Club during this period."

"We end the first half in a strong financial position, the business remains very cash generative and we are pleased to announce our first dividend payment. Looking ahead, we will continue to focus on our successful strategy, and by doing so, we are confident that we can deliver sustainable long-term growth."

H1 FY15 Highlights

£m

H1 FY15

H1 FY14

Change

FY14

Total revenue

381.5

346.2

10.2%

665.4

    Food

188.7

172.3

9.6%

327.1

    Accessories

159.6

147.7

8.0%

288.0

    Services & Other1

33.2

26.2

27.0%

50.3






Overall LFL growth2

4.2%

1.3%


2.4%

Merchandise LFL growth

3.7%

1.4%


2.4%

Services LFL growth

10.2%

0.0%


2.1%






Gross margin

53.8%

53.6%

20bps

53.8%

Underlying EBITDA3

58.6

52.9

10.8%

110.7

Underlying EBITDA margin

15.4%

15.3%

8bps

16.6%

Profit before tax

40.5

21.3


52.24

Net income5

31.5

15.3


38.6

Basic EPS (pence)

6.3

(3.4)


1.0

Dividend (pence)

1.8









Underlying unlevered FCF6

33.8

23.2


92.4

    Conversion7

57.7%

43.8%


83.4%

Leverage (Net Debt / underlying EBITDA)

2.0x8



2.3x






Number stores9

385

359

26

377

Number vets

303

233

70

277

    In store vets

182

128

54

158

    Standalone vets

121

105

16

119

Number Groom Rooms

152

103

49

129

 

1 Includes veterinary Joint Venture fees and other income, Groom Room revenue, revenue from live pet sales and insurance commission

2 'Like-for-Like' sales growth comprises total sales/fee revenue in a financial period compared to revenue achieved in a prior period, post cannibalisation, for stores, grooming salons and vets that have been trading for 52 weeks. LfL includes revenue from the Group's online operations

3 H1 FY15 underlying EBITDA excludes £0.8m of IFRS2 share based payment charges. H1 FY14 underlying EBITDA excludes £0.6m of related party management fees

4 Represents underlying trading profit before tax, excluding £10.6m of exceptional expenses and £19.2m of exceptional interest charge.

5 FY14 excludes exceptional tax credit. H1 FY15 excludes an exceptional tax credit of £4.3m, see page 10 for details

6 Underlying unlevered Free Cashflow is defined as Underlying EBITDA, adjusted for changes in working capital, acquisitions of property, plant and equipment and other intangible assets, investments in other financial assets, proceeds from the sale of property, plant and equipment and is stated before cash flows for exceptional costs and acquisitions of subsidiaries

7 Conversion represents underlying unlevered FCF as a percentage of underlying EBITDA

8 Represents last twelve months underlying EBITDA

9 Store portfolio net of 10 new stores, one permanent closure in the period, and one temporary closure of Rugby, which will be relocated in the H1 FY16

Results presentation

A presentation for analysts and investors will be held today at 9.30am at Clifford Chance, 10 Upper Bank St, E14 5JJ, attendance is by invitation only. An audio webcast and statement of these results will be available at http://investors.petsathome.com

 

Enquiries

Pets At Home Group Plc:                                                                 +44 (0) 161 486 6688

Amie Gramlick, Head Of Investor Relations

 

 

Media Enquiries:

Brunswick (Public Relations Advisors to Pets at Home):           +44 (0) 207 404 5959

Tim Danaher

Natalia Dyett

 

 

About Pets At Home

Pets At Home Group Plc is the UK's leading specialist pet omnichannel retailer and services provider.

Pets At Home operates from 385 stores located across the UK. The Group operates the UK's largest small animal veterinary business with 303 practices, run principally under a Joint Venture model using the Companion Care and Vets4Pets brand names. Pets at Home is the UK's leading operator of pet grooming services offered through its 152 Groom Room salons. The Group also owns and operates Ride-away, a specialist equine retail business with a York superstore, website and catalogue. For more information visit: http://investors.petsathome.com/

 

Disclaimer

 

This statement of interim financial results does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets At Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial advisor.

 

Certain statements in this statement of interim financial results constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement of interim financial results. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

 

Chief Executive's Review

 

Operational Key Performance Indicators

ROLLOUT



H1 FY15

H1

FY14

FY14







Stores

Number of stores in period


385 1

359

377

New stores (gross)


10

14

322







Vets

Number of vet practices (total)


303

233

277

      Of which Joint Venture practices


295

223

267

      Of which wholly owned Group Venture practices


8

10

10

Number of standalone vet practices


121

105

119

Number of in-store vet practices


182

128

158

      % of stores with vet


47%

36%

42%






New vet practices in period (total)


26

25

69

New standalone vet practices


2

7

22

New in-store vet practices


24

18

47


      Of which retrofits


15

7

18







Groomers

Number of groomers


152

103

129

      % of stores with groomer


39%

29%

34%

New groomers in period


23

16

42


      Of which retrofits


12

4

11







VIP CLUB



H1 FY15

H1

FY14

FY14


VIP Club members (m)


2.6

1.4

2.0


VIP swipe as % revenue 3


57% 4

39% 4

52% 5





1 Store portfolio net of 10 new stores, one permanent closure in the period, and one temporary closure of Rugby, which will be relocated in the H1 FY16

2 FY14 openings include new format store, Barkers

3 Represents swipe rate of store-only transactions

4 Average swipe rate over half year period

5 Average swipe rate over Q4 FY14 period

During the first half of the financial year 2015, we saw good progression against our three strategic levers:

·     Expanding like-for-like sales growth

·     Space rollout and footprint development

·     Continued focus on margin improvement

 

Expanding like-for-like growth

Product and innovation

A differentiated and unique offer is key to our strategy, improving customer loyalty and visit frequency. We have continued to refresh our product range, changing more than 2,100 SKUs (Stock Keeping Units) in the first half, representing nearly 30% of our total range. Of those products refreshed, over a third were private or own label products.

Range expansion and refreshment within Advanced Nutrition foods is of key strategic importance, driving growth in this higher margin product group. During the first half we added range extensions for both branded and own brand Advanced Nutrition, with extensions in Hills, Royal Canin, Applaws and increased pack sizes in our own brand Wainwright's. 

VIP Club

Our loyalty scheme, VIP Club, allows us to send personalised and targeted marketing offers to owners and their pets, and will continue to be one of the key levers through which we can take further market share. VIP continued to gain strong traction from engaged pet owners, adding 600,000 members in the first half of the financial year to reach a total of 2.6 million members, and now has over 9 million pets registered on its database. VIP card swipe rate represented 57% of revenues captured on store tills, compared with 52% at the end of FY14.

Whilst VIP Club is still young, having launched just under two years ago, our VIPs are already becoming more valuable and increasing their share of pet spend with us. We estimate our share of our customers' total pet spend in the market from VIPs less than 6 months old is 38%, compared with 47% for VIPs over 12 months old.

Omnichannel

Traffic and visits to our website, PetsAtHome.com, have continued to grow strongly during the period and our share of online pet market traffic remains strong at 45%. As well as creating direct online sales, econometrics analysis indicates one in every 14 visits to our website generates an in-store transaction. This measure has improved since the website relaunch in January, improving the efficiency of the new site at driving customers to purchase in stores.  Vet appointments can also be booked online through the Vets4Pets website, which drives further transactions in our practices and stores.

Deliver To Store (DTS) became fully operational in August, enhancing our omnichannel shopping experience for customers. DTS allows customers to order products for pickup within 48 hours which are not currently in stock at their local store. This includes the extended online only range of 3,400 SKUs, bringing the total online range to over 10,800 SKUs. Our Click and Collect (C&C) service, which allows customers to place an order on the website for collection in store within two hours, continues to perform well. Whilst some C&C sales have been substituted by DTS, which is at an early stage, we believe DTS is delivering incremental sales to our omnichannel segment.

Looking ahead, we will continue to invest and plan to launch mobile and tablet friendly website versions in the final quarter of FY15 and increase our online product range towards a target of c14,000 SKUs. We will also enable the redemption of VIP vouchers online before financial year end, creating a seamless store and online shopping experience for VIP customers, as well as allowing us to track offer redemption rates and measure success and returns more easily.

Services

Retrofitting of veterinary practices and Groom Room salons to existing stores increases like-for-like store sales, by enhancing our overall proposition, driving store footfall and enabling cross-selling of products. During the first half, 15 veterinary practices and 12 Groom Room salons were added to existing stores.

Marketing

We returned to TV during the period, with our highly engaging advertisement 'My Pet Moments' featuring pet video clips crowd sourced from our customers. Audience responses have shown an increased love and appeal for Pets At Home, a stronger reception than prior campaigns.

Engagement

Customer engagement is central to the Group's success, creating loyalty and like-for-like sales growth. During the half year, customer advocacy, measured by a Net Promoter Score from over 8000 customers, was 85%, compared with the FY14 level of 84%.



Space rollout

A key part of the Group's strategy is to increase the number of stores, in-store and standalone veterinary practices, and Groom Room salons. During the first half, we continued to execute on our growth strategy. We finished the period with 385 stores, adding 8 stores net to the portfolio; including 10 new stores, one end of lease store closure in Knutsford, and a temporary closure of our Rugby store which will be relocated in the first half of FY16.

We opened 26 vet practices, bringing the total portfolio to 303, consisting of 182 in-store and 121 standalone vets. All new vet practices are opened under the Vets4Pets brand and we continue to work on the rebranding of Companion Care (CC) practices with our Joint Venture Vet partners. During the period, 20 CC practices rebranded to Vets4Pets, bringing the total number of Vets4Pets practices in the portfolio to 208. These practices are now benefitting from our national advertising campaign.

Groom Room openings also progressed strongly, with 23 new salons, taking the total number of Groom Rooms to 152.

The performance and returns on new stores, vet practices and Groom Rooms remain in line with our expectations.

Focus on margin

Advanced Nutrition (AN) growth and own brand participation are supportive to Merchandise margin, which expanded modestly by 7bps to 55.9% in H1 FY15 (H1 FY14: 55.9%). During the period, AN revenues grew by 18.9% to £75.4m (H1 FY14: £63.4m), with our private label product Wainwright's an important contributor, growing by 54.8% to £20.5m (H1 FY14: £13.2m). Wainwright's growth has been boosted by new additions such as Grain Free for dogs, and Wainwright's for cat, which were launched in the H2 FY14 period. AN now represents 59% of total dog and cat food revenues, excluding food treats (H1 FY14: 55%).

 

Own brand and private label products represented 42.1% of gross store revenues during the H1 FY15 (H1 FY14: 41.4%).  To facilitate this growth, we continue to increase space allocated to Advanced Nutrition within stores, with the latest move completed in October 2014 post the end of the half year.

Services gross margin, which expanded to 31.7% in the H1 FY15 (H1 FY14: 26.2%), has expanded through the growing maturity of our veterinary practices, as well as synergies from our acquisition of Vets4Pets in FY14. As the vet practices mature and reach higher utilisation rates, there is an opportunity for our revenue stream to increase without a significant rise in our cost base, delivering margin leverage. Within the Groom Room business, new salons can be dilutive in the early years, with maturity achieved after five years. 

 

 

Nick Wood

Chief Executive Officer

4 December 2014

 



 

Chief Financial Officer's Review

 

The H1 FY15 accounting period represents the 28 week period from 28th March to 9th October 2014. The comparative H1 FY14 period represents the 28 week period from 29th March to 10th October 2013.

 

Financial Key Performance Indicators

FINANCIALS

 

 

 

 

Revenue


H1 FY15

H1 FY14

Change

Revenue Split (£m)




Food

188.7

172.3

9.6%

Accessories

159.6

147.7

8.0%

Total Merchandise revenue1

348.3

320.0

8.9%

Services & Other revenue2

33.2

26.2

27.0%

Total Group revenue

381.5

346.2

10.2%

 

Like For Like growth3

4.2%

1.3%


Merchandise LFL growth

3.7%

1.4%


Services LFL growth

10.2%

0.0%






Revenue Mix (% of total revenues)




Food

49.5%

49.7%

 

Accessories

41.8%

42.7%

 

Total Merchandise

91.3%

92.4%

 

Services & other

8.7%

7.6%

 





Gross Margin

Merchandise Gross Margin

55.9%

55.9%

7 bps

Services & Other Gross Margin

31.7%

26.2%

546 bps

Total Gross Margin

53.8%

53.6%

20 bps






EBITDA

Underlying EBITDA (£m)

58.6

52.9

10.8%

Underlying EBITDA margin

15.4%

15.3%

8 bps






Other

Income Statement

Profit before tax

40.5

21.3


Net income4

31.5

15.3


Basic EPS (pence)

6.3

(3.4)


Dividend (pence)

1.8








Cashflow & Leverage

Underlying unlevered FCF5

33.8

23.2

45.7%

    Conversion6

57.7%

43.8%

1390bps

CROIC

21.4%

-


Leverage (Net Debt / underlying EBITDA)

2.0x7



 

1 Includes Food and Accessories revenue

2 Includes veterinary Joint Venture fees and other income, Groom Room revenue, revenue from live pet sales and insurance commission

3 'Like-for-Like' sales growth comprises total sales/fee revenue in a financial period compared to revenue achieved in a prior period, post cannibalisation, for stores, grooming salons and vets that have been trading for 52 weeks. LfL includes revenue from the Group's online operations

4 H1 FY15 excludes an exceptional tax credit of £4.3m, see page 10 for details

5 Underlying unlevered Free Cashflow is defined as Underlying EBITDA, adjusted for changes in working capital, acquisitions of property, plant and equipment and other intangible assets, investments in other financial assets, proceeds from the sale of property, plant and equipment and is stated before cash flows for exceptional costs and acquisitions of subsidiaries

6 Conversion represents underlying unlevered FCF as a percentage of underlying EBITDA

7 Represents last twelve months underlying EBITDA



Sales and revenue

Total revenues in H1 FY15 grew by 10.2% to £381.5m (H1 FY14: £346.2m), with strong performance in all categories; food, accessories and services. Like-for-like sales grew by 4.2%driven by strength in Advanced Nutrition, Health & Hygiene, VIP Club momentum, and continued growth in fee income from our veterinary practices and Groom Rooms. Some of the strength in like-for-like growth can be attributed to annualising a weaker comparable in the Q1 FY14, when we experienced a period of sustained hot weather in the UK, which negatively impacted sales by c£2.6m. Adjusting for this weather impact, underlying like-for-like growth in the H1 FY15 was 3.4%.

 

Total merchandise revenues, which includes Food and Accessories, grew by 8.9% to £348.3m (H1 FY14: £320.0m).

Food revenues grew strongly by 9.6% to £188.7m (H1 FY14: £172.3m), reflective of strong performance in dog and cat Advanced Nutrition (AN) and frozen dog foods. AN revenues grew 18.9% to £75.4m (H1 FY14: £63.4m), with our private label product Wainwright's an important contributor, growing by 54.8% to £20.5m (H1 FY14: £13.2m). Grocery food performance was weaker, mainly driven by our continued re-allocation of space in stores towards AN. Wild bird food sales also saw some weakness, impacted by both the mild weather and competitor discounting. We have subsequently introduced a value range of wild bird foods to stores and are encouraged by the early performance of this range.

 

Accessories, revenues grew by 8.0% to £159.6m (H1 FY14: £147.7m), driven by Health and Hygiene sales which were boosted positively by the mild weather, cat accessories, and dog collars and leads. We experienced some weakness in Cat Litter, and in Aquatics. Aquatics weakness has been mainly driven by re-allocation of this space into services when vet practices and Groom Rooms are retrofitted to stores.

 

Services revenues grew 27.0% to £33.2m (H1 FY14: £26.2m), reflecting both new openings and the growing revenue streams from our maturing vet practices and Groom Rooms. Our Joint Venture veterinary practices continue to grow well ahead of market rates, generating fee income to Pets At Home of £14.8m (H1 FY14: £11.4m), representing a growth of 30.4% on the prior year.

 

Gross margin

Group H1 FY15 margin expanded by 20bps to 53.8% (H1 FY14: 53.6%), attributable mainly to the expansion in the gross margin of our Services business.

 

Gross margins within Merchandise were 55.9%, a modest expansion of 7 bps (H1 FY14: 55.9%), notwithstanding price investing in large accessories online and instore, and introducing a value range of wild bird feeds. This has been achieved through the mix of own brand participation, particularly the performance of Wainwright's Advanced Nutrition, improvements in terms with suppliers, and benefits from our dedicated Asia sourcing office.  

 

Gross margin within the services business expanded by 546 bps to 31.7% (H1 FY14: 26.2%). The main contributors to expansion have been the continued delivery of synergies from the Vets4Pets acquisition and the growing maturity of both our vet practices and Groom Rooms. Synergies delivered an incremental £1.8m to Services gross profit in the H1 FY15. Whilst our Groom Rooms are contributing to gross margin growth, there is a dilutive effect as many salons are still immature. Services and other gross margin was also negatively impacted by our investment in live pet care within stores, where we continually invest to improve welfare standards.

 

We continue to expect an overall improvement in Group gross margin for the FY15. This will be driven by modest Merchandise margin expansion, alongside a larger Services margin expansion. Services gross margin will see a continued benefit from maturation and growth, and the final delivery of synergies from the Vets4Pets acquisition.

 

Operating costs

Selling and distribution expenses of £137.7m were constant as a percentage of Group revenue at 36.1% (H1 FY14: 36.2%). Occupation costs (rent, services charges and other costs) declined as a percentage of sales as we continue to benefit from a relatively benign rental market, as well as the offset to our rental costs from the retrofitting of vet practices to stores. Vet practices within stores pay an average rental contribution of £39,000 per practice to Pets At Home for the space occupied in store and contributed a £3.5m offset to our rental costs in H1 FY15 (H1 FY14: £2.6m). Colleague costs increased as a result of our high retention rates and 'Learn to Earn' 'Steps' training programme, and marketing costs were higher due to the increased investment in TV advertising and sponsorship.

 

Administration expenses of £21.8m were 5.7% of revenue (H1 FY14: 5.4%), mainly reflecting an additional £1.4m of costs associated with being a publicly listed company and £0.8m of IFRS2 share based payment charges. Excluding these costs, admin expenses would have declined to 5.1% of total revenues.

 

Underlying EBITDA

Underlying EBITDA of £58.6m represented a 10.8% increase on the previous year (H1 FY14: £52.9m), with an expansion in margin to 15.4% (H1 FY14: 15.3%). Underlying EBITDA excludes £0.8m of IFRS2 share based payment charges, to aid comparability with the prior year, during our first year as a public company.

The margin expansion is reflective of margin expansion in our Services business, from vets and Groom Rooms, which are margin accretive to the Group at an EBITDA level. Offsetting this margin leverage, this financial year, is the additional cost associated with being a publicly listed company, of £1.4m.

 

£m

H1 FY15

H1 FY14

Operating profit

45.8

41.7

Related party fees

-

0.7

IFRS share based payment charges

0.8

-

Depreciation and amortisation

12.0

10.5

Underlying EBITDA

58.6

52.9

 

H1 FY14 underlying EBITDA negatively impacted by c£1.5m due to sustained hot weather experienced during the period.

Underlying EBITDA is calculated as Group underlying operating profit under IFRS (which includes amortisation of landlord and developer contributions received), plus depreciation and amortisation and profits and losses on disposal where these are included in operating profit. Excludes exceptional items, related party fees, and IFRS2 related share based payment credits and charges

 

Finance expense

Net finance expense for the half year period was £5.4m. We expect total net finance expense for the FY15 period to be £9.6 - 9.8m.

 

Taxation, net income & EPS

Underlying total tax expense for the period was £8.9m, a rate of 22.0% on pre tax profit, and in line with our expected tax rate for the full financial year. An exceptional tax credit of £4.3m related to the release of a provision made in the previous financial year in respect of interest deductability on debt associated with the pre IPO capital structure of the business.

Underlying trading profit for the period, after tax, was £31.5m (H1 FY14: £15.3m). Basic earnings per share, calculated on 500m shares in issue, were 6.3 pence.

 

Cash flows

Cash flow generation remains strong. The Group generated £49.1m in underlying operating cash flow during the period (H1 FY14: £38.4m). Underlying unlevered free cash flow before interest, tax and acquisitions was £33.8m (H1 FY14: £23.2m), representing a cash conversion rate of 57.7% (H1 FY14: 43.8%).

Underlying free cash flow has been adjusted through the use of underlying EBITDA, which excludes £0.8m of IFRS2 share based payment charges.

 

Borrowings and net debt

The Group's underlying net debt position at the end of the half year period was £232.8m, which represents a leverage ratio of 2.0x underlying EBITDA, a reduction from the FY14 position of 2.3x. We continue to expect further de-leverage in the second half of the financial year.

 

£m

Leverage

Gross Debt

325.0

Cash

(92.2)

Net debt

232.8



Last twelve months underlying EBITDA

116.4

Leverage

2.0x

 

Working capital

The working capital balance increased by £10.2m during the first half period to £(23.2)m (FY14 underlying working capital position of £(33.4)m).

An increase in inventory of £5.8m reflects new store openings and the arrival of our Christmas stock ready for distribution into stores. Of the increase in trade receivables of £6.1m, half of the movement relates to a loan made to our Employee Benefit Trust (EBT), to facilitate an IPO related all-colleague bonus payment. The EBT holds shares in the Group which can be realised to settle the loan. The remainder of the receivables movement is linked to balances with new Joint Venture vet practices, whereby the Group funds initial setup costs until commercial funding is drawn down by the practice.The increase in trade payables of £1.7m, excluding the reduction in IPO related payables of £25.2m, is reflective of overall business growth.

 

Capital expenditure

Capital expenditure for the H1 FY15 was £14.6m (H1 FY14: £14.9m), of which the majority is represented by new store openings and refurbishments to allow the retrofitting of vet practices and Groom Rooms. New store capital expenditure totalled £5.7m (H1 FY14: £6.4m), whilst refurbishment capex, which often includes the requirement for a mezzanine floor installation, totalled £5.3m (H1 FY14: £1.9m). During the period, 5 new stores and 5 retrofits incorporated a mezzanine installation (H1 FY14: 3 mezzanines into new stores). We continued to enhance our business systems with £2.1m of capital investment during the period.

We continue to expect total capital expenditure for the financial year to be in the region of £34-35m.

 

Dividend

The Board has declared an interim dividend of 1.8 pence per share, payable on the 16th January 2015 to shareholders on the register at the close of trading on 12th December 2014.  The Board is confident in targeting a total full year dividend payment of between 35-40% of earnings, reflective of the positive outlook for the business.

 

 

Ian Kellett

Chief Financial Officer

4 December 2014

 



 

Risks and Uncertainties

An effective risk management process has been adopted to help the Group achieve its strategic objectives and enjoy long term success. The Board does not consider that the principal risks and uncertainties have changed since the publication of the annual report for the year ended 27 March 2014. These comprise:

·     Protecting reputation

·     Competition with other retailers and vet practices, including other pet specialists, supermarkets, discounters, and online retailers

·     Stores and services expansion and rollout

·     Retaining and developing engaged colleagues

·     Keeping core business systems up to date and with the capability to support the Group's growth plans

·     Supply chain and sourcing risk

·     Liquidity and credit risk

·     Treasury and financial risk from exposure to US dollar fluctuations, in respect of goods sourced from Asia

A detailed explanation of these risks can be found on pages 48 to 51 of the 2014 Annual Report which is available at http://investors.petsathome.com

 

Responsibility Statement

 

We confirm that to the best of our knowledge:

 

·     the condensed set of financial statements has been prepared in accordance with IAS 34 Interim Financial Reporting as adopted by the EU;

 

·     the interim management report includes a fair review of the information required by:

 

(a)  DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statemetns; and a description of the principal risks and uncertainiies for the remaining six months of the year; and

(b)  DTR 4.2.8R of the Disclosure and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period; and any changes in the related party transactions described in the last annual report that could do so.

 

By order of the Board on 3 December 2014

 

 

Nick Wood, Chief Executive Officer                                       Ian Kellett, Chief Financial Officer

 

 

 

 

Independent Review Statement

 

INDEPENDENT REVIEW REPORT TO PETS AT HOME GROUP PLC 

Introduction 

We have been engaged by the company to review the condensed set of financial statements in the half-yearly financial report for the 28 week period ended 9 October 2014 which comprises the Condensed Consolidated Income Statement, the Condensed Consolidated Statement of Comprehensive Income, the Condensed Consolidated Balance Sheet, the Condensed Consolidated Statement of Cash Flows, the Condensed Consolidated Statement of Changes in Equity and the related explanatory notes.  We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements. 

This report is made solely to the company in accordance with the terms of our engagement to assist the company in meeting the requirements of the Disclosure and Transparency Rules ("the DTR") of the UK's Financial Conduct Authority ("the UK FCA").  Our review has been undertaken so that we might state to the company those matters we are required to state to it in this report and for no other purpose.  To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company for our review work, for this report, or for the conclusions we have reached. 
Directors' responsibilities 

The half-yearly financial report is the responsibility of, and has been approved by, the directors.  The directors are responsible for preparing the half-yearly financial report in accordance with the DTR of the UK FCA. 

As disclosed in note 1, the annual financial statements of the Group are prepared in accordance with IFRSs as adopted by the EU.  The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with IAS 34Interim Financial Reporting as adopted by the EU

Our responsibility 

Our responsibility is to express to the company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review. 

Scope of review 

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Auditing Practices Board for use in the UK.  A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures.  A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit.  Accordingly, we do not express an audit opinion. 

Conclusion 

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the 28 week period ended 9 October 2014 is not prepared, in all material respects, in accordance with IAS 34 as adopted by the EU and the DTR of the UK FCA. 

 

 

David Bills

for and on behalf of KPMG LLP 

Chartered Accountants 

St James' Square

Manchester

M2 6DS

3 Dec 2014

 


Condensed Consolidated Income Statement

 


Note

28 week period ended

9 October 2014

28 week period ended

9 October 2014

28 week period ended

9 October 2014

28 week period ended

10 October 2013

52 week period ended

27 March 2014

52 week period ended

27 March 2014

52 week period ended

 27 March 2014



 

£000

 

£000

 

£000

 

£000

 

£000

 

£000

 

£000



 

Underlying Trading

 

Exceptional Items (note 6)

 

Total

 

Total

 

Underlying Trading

 

Exceptional Items (note 3)

 

Total










Revenue

2

381,521

-

381,521

346,153

665,395

-

665,395

Cost of sales


(176,212)

-

(176,212)

(160,564)

(307,271)

-

(307,271)



             

             

             

             

             

             

             

Gross profit


205,309

-

205,309

185,589

358,124

-

358,124










Selling and distribution expenses

(137,662)

-

(137,662)

(125,286)

(233,891)

-

(233,891)

Administrative expenses


(21,812)

-

(21,812)

(18,579)

(34,817)

(10,574)

(45,391)



             

             

             

             

             

             

             

Operating profit

3

45,835

-

45,835

41,724

89,416

(10,574)

78,842

Financial income


200

-

200

183

368

-

368

Financial expense

5

(5,562)

-

(5,562)

(20,606)

(37,547)

(19,158)

(56,705)



             

             

             

             

             

             

             

Net financing expense


(5,362)

-

(5,362)

(20,423)

(37,179)

(19,158)

(56,337)



             

             

             

             

             

             

             

Profit before tax


40,473

-

40,473

21,301

52,237

(29,732)

22,505

Taxation

6

(8,924)

4,295

(4,629)

(5,976)

(13,672)

4,715

(8,957)



             

             

             

             

             

             

             

Profit for the period


31,549

4,295

35,844

15,325

38,565

(25,017)

13,548



             

             

             

             

             

             

             

 

 

Basic and diluted earnings per share attributable to equity shareholders of the Company

 

Note

28 week period

 ended

9 October 2014

28 week period

 ended

10 October 2013

52 week period

 ended

 27 March 2014

 

 

 

 

 

Equity holders of the parent - underlying trading

4

£0.06

(£0.03)

£0.01

Equity holders of the parent - after exceptional items

4

£0.07

 

(£0.03)

(£0.14)

There is no dilutive impact on earnings per share in any of the reported periods.

 


 

Condensed Consolidated Statement of Comprehensive Income

 

 

 

28 week period ended

 9 October 2014

28 week period ended

 10 October 2013

52 week period ended

 27 March 2014

 

 

 

 

 

 

 

£000

£000

£000

 

 

 

 

 

Profit for the period

 

35,844

15,325

13,548

 

 

 

 

 

Other comprehensive income

 

 

 

 

Items that are or may be recycled subsequently into profit or loss:

 

 

 

 

Foreign exchange translation differences

 

2

2

5

Cash flow hedges - reclassified to profit and loss

 

812

(811)

(811)

Effective portion of changes in fair value of cash flow hedges

 

175

1,341

1,442

 

 

             

             

             

Other comprehensive income for the period, before income tax

 

989

532

636

 

 

 

 

 

Income tax on other comprehensive income

 

(197)

(106)

(159)

 

 

             

             

             

 

 

 

 

 

Other comprehensive income for the period, net of income tax

 

792

426

477

 

 

             

             

             

 

 

 

 

 

Total comprehensive income for the period

 

36,636

15,751

14,025

 

 

             

             

             

The notes on pages 8 to 23 form an integral part of these financial statements.

Condensed Consolidated Balance Sheet

 

Note

At 9 October 2014

At 10 October 2013

At 27 March 2014

 

 

 

 

 

 

 

£000

£000

£000

 

 

 

 

 

Non-current assets

 

 

 

 

Property, plant and equipment

7

96,589

84,687

93,628

Intangible assets

8

955,020

955,296

955,238

Other financial assets

 

7,421

4,610

6,619

 

 

             

             

             

 

 

1,059,030

1,044,593

1,055,485

 

 

             

             

             

Current assets

 

 

 

 

Inventories

 

51,924

49,375

46,116

Deferred tax assets

 

11

-

45

Other financial assets

 

344

194

-

Trade and other receivables

 

48,097

40,570

42,159

Cash and cash equivalents

 

92,228

26,670

90,823

 

 

             

             

             

 

 

192,604

116,809

179,143

 

 

             

             

             

Total assets

 

1,251,634

1,161,402

1,234,628

 

 

             

             

             

Current liabilities

 

 

 

 

Other interest-bearing loans and borrowings

9

(5,000)

(12,408)

-

Trade and other payables

 

(129,103)

(101,114)

(149,547)

Provisions

 

(307)

(743)

(461)

Other financial liabilities

 

-

(747)

(1,113)

Deferred tax liabilities

 

-

(984)

-

 

 

             

             

             

 

 

(134,410)

(115,996)

(151,121)

 

 

             

             

             

Non-current liabilities

 

 

 

 

Other interest-bearing loans and borrowings

9

(315,420)

(534,196)

(319,855)

Other payables

 

(31,836)

(49,638)

(31,068)

Provisions

 

(1,772)

(1,457)

(1,835)

 

 

             

             

             

 

 

(349,028)

(585,291)

(352,758)

 

 

             

             

             

Total liabilities

 

(483,438)

(701,287)

(503,879)

 

 

             

             

             

Net assets

 

768,196

460,115

730,749

 

 

             

             

             

Equity attributable to equity holders of the parent

 

 

 

 

Ordinary share capital

 

5,000

1,659

5,000

Share premium

 

-

291,492

1,080,477

Additional paid in capital

 

-

503,293

-

Consolidation reserve

 

(372,026)

(372,026)

(372,026)

Merger reserve

 

113,321

113,321

113,321

Cash flow hedging reserve

 

428

(410)

(362)

Translation reserve

 

6

1

4

Retained earnings

 

1,021,467

(77,215)

(95,665)

 

 

             

             

             

Total equity

 

768,196

460,115

730,749

 

 

             

             

             

Company number: 08885072

The notes on pages 8 to 23 form an integral part of these financial statements.


Condensed Consolidated Statement of Changes in Equity

 

 


 

 

 

Share

capital

 

 

 

Share premium

 

 

 

Consolidation reserve

 

 

 

Merger reserve

 

 

 

Cash flow hedging reserve

 

 

 

Translation

reserve

 

 

 

Retained

earnings

 

 

 

Total

equity











£000

£000

£000

£000

£000

£000

£000

£000










Balance at 27 March 2014

5,000

1,080,477

(372,026)

113,321

(362)

4

(95,665)

730,749










Total comprehensive income for the period


















Profit for the period

-

-

-

-

-

-

35,844

35,844

Other comprehensive income

-

-

-

-

790

2

-

792











             

             

             

             

             

             

             

             

Total comprehensive income for the period

-

-

-

-

790

2

35,844

36,636


             

             

             

             

             

             

             

             

Transactions with owners, recorded directly in equity


















Cancellation of share premium (i)

-

(1,080,477)

-

-

-

-

1,080,477

-

Share based payment transactions

-

-

-

-

-

-

811

811


             

             

             

             

             

             

             

             

Total contributions by and distributions to owners

-

(1,080,477)

-

-

-

-

1,081,288

811


             

             

             

             

             

             

             

             

Balance at 9 October 2014

5,000

-

(372,026)

113,321

428

6

1,021,467

768,196


             

             

             

             

             

             

             

             

 

 

 

           (i) As contemplated in the Pets at Home Group Plc IPO Prospectus dated 28 February 2014 and pursuant to a shareholder resolution passed on 27 February 2014, Pets at Home Group Plc completed a reduction of capital, whereby £1,080,477,000 standing to the credit of the Company's share premium account was cancelled, creating distributable reserves of an equivalent amount.  The cancellation was formally approved by the High Court, and the court order was registered by the Registrar of Companies and became effective on 30 July 2014. The cancellation has no effect on the overall net asset position of the Company and/or its group.

 

 

 

 

Condensed Consolidated Statement of Changes in Equity


 

 

 

Share

capital

 

 

 

Share premium

 

 

 

Additional paid in capital

 

 

 

Consolidation reserve

 

 

 

Merger reserve

 

 

Cash flow hedging reserve

 

 

 

Translation

reserve

 

 

 

Retained

earnings

 

 

 

Total

equity












£000

£000

£000

£000

£000

£000

£000

£000

£000











Balance at 28 March 2013

1,659

291,492

612,680

(372,026)

113,321

(834)

(1)

(71,567)

574,724











Total comprehensive income for the period




















Profit for the period

-

-

-

-

-

-

-

15,325

15,325

Other comprehensive income

-

-

-

-

-

424

2

-

426












             

             

             

             

             

             

             

             

             

Total comprehensive income for the period

-

-

-

-

-

424

2

15,325

15,751


             

             

             

             

             

             

             

             

             

Transactions with owners, recorded directly in equity




















Dividends on additional paid in capital (see note 1)

-

-

20,973

-

-

-

-

(20,973)

-

Redemption of additional paid in capital

-

-

(130,360)

-

-

-

-

-

(130,360)


             

             

             

             

             

             

             

             

             

Total contributions by and distributions to owners

-

-

(109,387)

-

-

-

-

(20,973)

(130,360)


             

             

             

             

             

             

             

             

             

Balance at 10 October 2013

1,659

291,492

503,293

(372,026)

113,321

(410)

1

(77,215)

460,115


             

             

             

             

             

             

             

             

             

 

 

 

Condensed Consolidated Statement of Changes in Equity


 

 

 

Share

capital

 

 

 

Share premium

 

 

 

Additional paid in capital

 

 

 

Consolidation reserve

 

 

 

Merger reserve

 

 

Cash flow hedging reserve

 

 

 

Translation

reserve

 

 

 

Retained

earnings

 

 

 

Total

equity












£000

£000

£000

£000

£000

£000

£000

£000

£000











Balance at 10 October 2013

1,659

291,492

503,293

(372,026)

113,321

(410)

1

(77,215)

460,115











Total comprehensive income for the period




















Profit for the period

-

-

-

-

-

-

-

(1,777)

(1,777)

Other comprehensive income

-

-

-

-

-

48

3

-

51


             

             

             

             

             

             

             

             

             

Total comprehensive income for the period

-

-

-

-

-

48

3

(1,777)

(1,726)


             

             

             

             

             

             

             

             

             

Transactions with owners, recorded directly in equity




















Issue of shares (i)

1,405

342,916

(344,321)

-

-

-

-

-

-

Issue of  shares (ii)

40

9,697

-

-

-

-

-

-

9,737

Issue of  shares (iii)

1,896

462,574

-

-

-

-

-

-

464,470

Share issue costs

-

(26,202)

-






(26,202)

Dividends on additional paid in capital

-

-

16,673

-

-

-

-

(16,673)

-

Redemption of additional paid in capital

-

-

(175,645)





-

(175,645)


             

             

             

             

             

             

             

             

             

Total contributions by and distributions to owners

3,341

788,985

(503,293)

-

-

-

-

(16,673)

272,360


             

             

             

             

             

             

             

             

             

Balance at 27 March 2014

5,000

1,080,477

-

(372,026)

113,321

(362)

4

(95,665)

730,749


             

             

             

             

             

             

             

             

             

(i)            On 17 March 2014 the Company issued 140,539,069 ordinary £0.01 shares at a premium of £2.44 per share in exchange for £344,321,000 additional paid in capital issued by PAH Lux S.a.r.l.

(ii)           On 17 March 2014, the Company issued 3,974,537 ordinary £0.01 shares at a premium of £2.44 per share in exchange for shares issued by a subsidiary.

(iii)          On 17 March 2014 the Company issued 189,579,314 ordinary £0.01 shares at a premium of £2.44 per share. Share issue costs of £26,202,000 were offset against the gross proceeds of £464,470,000.


Condensed Consolidated Statement of Cash Flows



28 week period

 ended

9 October 2014


28 week period

ended

10 October 2013


52 week period ended

27 March 2014










£000


£000


£000

Cash flows from operating activities







Profit for the period


35,844


15,325


13,548

Adjustments for:







Depreciation and amortisation


11,948


10,515


19,990

Financial income


(200)


(183)


(368)

Financial expense


5,562


20,606


56,705

Loss on sale of PPE


-


-


77

Taxation (i)


4,629


5,976


8,957

Share based payment charges


811


-


31



             


             


             



58,594


52,239


98,940

Increase in trade and other receivables


(5,938)


(6,529)


(7,969)

Increase in inventories


(5,808)


(7,319)


(4,060)

Increase/(decrease) in trade and other payables

2,984


(120)


21,740


(Decrease)/increase in IPO related trade and other payables (ii)

(25,184)


-


25,184


Total (decrease)/increase in trade and other payables


(22,200)


(120)


46,924

(Decrease)/increase in provisions


(217)


(94)


2



             


             


             



24,431


38,177


133,837

Tax payable - underlying (i)

(6,300)






Tax receivable - exceptional (i)

4,295






Tax paid


(2,005)


(4,666)


(9,192)



             


             


             

Net cash from operating activities


22,426


33,511


124,645



             


             


             

Cash flows from investing activities







Proceeds from sale of PPE


-


-


-

Interest received


51


183


368

Investment in other financial assets


(1,273)


(988)


(1,753)

Acquisition of subsidiary, net of cash acquired


-


(2,000)


(2,000)

Acquisition of PPE and other intangible assets


(14,582)


(14,905)


(26,278)



             


             


             

Net cash used in investing activities


(15,804)


(17,710)


(29,663)



             


             


             

Cash flows from financing activities







Proceeds from the issue of ordinary share capital


-


-


464,470

Share issue costs


-


-


(26,202)

Debt issue costs


-


(5,336)


(10,494)

Repayment of paid in capital


-


(130,400)


(306,005)

Proceeds from new loan


-


135,000


460,000

Repayment of borrowings


-


(3,708)


(585,260)

Interest paid


(5,217)


(16,280)


(32,261)



             


             


             

Net cash used in financing activities


(5,217)


(20,724)


(35,752)



             


             


             

Net increase/(decrease) in cash and cash equivalents


1,405


(4,923)


59,230

Cash and cash equivalents at beginning of period


90,823


31,593


31,593



             


             


             

Cash and cash equivalents at end of period


92,228


26,670


90,823



             


             


             

(i)             The tax charge is stated after the offset of the exceptional tax credit of £4,295,000 (note 6). Tax paid of £2,005,000 is stated after the offset of the exceptional tax credit of £4,295,000.

(ii)            The IPO related payables at 27 March 2014 of £25,184,000 related to costs incurred as part of the IPO on 17 March 2014, which were included in accruals and other creditors at the period end date, which have been settled in full in the period to 9 October 2014.

 



 

Notes

 

1          Basis of preparation

 

Pets at Home Group Plc (the Company) is a company incorporated in the United Kingdom and its registered office is Epsom Avenue, Stanley Green, Handforth, Cheshire, SK9 3RN.

The company is listed on the London Stock Exchange.

The condensed consolidated interim financial statements as at and for the 28 week period ended 9 October 2014 comprise the Company and its subsidiaries (together referred to as the Group).

The consolidated financial statements of the Group as at and for the 52 week period ended 27 March 2014 are available on request from the Company's registered office and via the Company's website.

The consolidated financial statements are prepared on the historical cost basis except for derivative financial instruments, share based payments and certain investments measured at their fair value.

 

Statement of compliance

 

These condensed consolidated interim financial statements have been prepared in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority and with IAS34 Interim Financial Reporting as adopted by the EU. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group as at and for the 52 week period ended 27 March 2014.

 

The financial information included in this interim statement of results does not constitute statutory accounts within the meaning of Section 435 of the Companies Act 2006 (the "Act"). The statutory accounts for the 52 weeks ended 27 March 2014 have been reported on by the Company's auditors and delivered to the Registrar of Companies. The auditor's report was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498(2) or (3) of the Companies Act 2006.

 

Going concern

 

The directors of Pets at Home Group Plc, having made appropriate enquiries, consider that adequate resources exist for the Group to continue in operational existence for the foreseeable future and that, therefore, it is appropriate to adopt the going concern basis in preparing the condensed consolidated interim financial statements as at and for the 28 week period ended 9 October 2014.

 

Significant accounting policies

 

The accounting policies adopted in preparation of the condensed consolidated interim financial statements as at and for the 28 week period ended 9 October 2014 are consistent with the policies applied by the Group in its consolidated financial statements as at and for the 52 week period ended 27 March 2014, except as described below:

·      Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual profit or loss.

The following standards and interpretations, issued by the International Accounting Standards Board or the International Financial Reporting Interpretations Committee, have been adopted by the Group with no significant impact on its consolidated financial statements:

·      IFRS 10 'Consolidated financial statements'

·      IFRS 11 'Joint arrangements'

·      IFRS 12 'Disclosure of interests in other entities'

·      IAS 27 'Separate financial statements'

·      IAS 28 'Investments in associates and joint ventures'

·      IAS 32 (Amendment) 'Financial instruments: presentation - offsetting financial assets and liabilities'.

 

 



 

Notes (continued)

 

1          Basis of preparation (continued)

 

Basis of consolidation

 

On 17 March 2014, the entire share capital of the Group's previous parent company Pets at Home Lux S.a.r.l was acquired by Pets at Home Group Plc funded by an issue of shares in Pets at Home Group Plc in exchange for these shares. On the same date a number of other transactions were completed to swap debt and additional paid in capital held outside of the Group for ordinary shares in Pets at Home Group Plc.

Whilst the equity instruments of Pets at Home Lux S.a.r.l were legally acquired, in substance the Directors have determined that the transaction represents a continuation of the Pets at Home Lux S.a.r.l business. As such, this transaction has been accounted for as a reverse acquisition. Further details of this transaction can be found within the significant accounting policies section of the Group's financial statements for the 52 week period ended 27 March 2014, which are available on the Company's website.

 

Accounting estimates and judgments

The preparation of the condensed consolidated interim financial statements in conformity with the Disclosure and Transparency Rules of the Financial Conduct Authority and with IAS34 Interim Financial Reporting as adopted by the EU requires management to make judgments, estimates and assumptions concerning the future that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.  These judgments are based on historical experience and management's best knowledge at the time and the actual results may ultimately differ from these estimates.  Estimates and underlying assumptions are reviewed on an ongoing basis and revisions to accounting estimates are recognised in the period in which the estimates are revised and in any future periods affected. 

The estimates and assumptions that have significant risk of causing a material adjustment to the carrying value of assets and liabilities are discussed below.

Carrying value of inventories

The Directors review the market value of and demand for its inventories on a periodic basis to ensure inventory is recorded in the financial statements at the lower of cost and net realisable value.  Any provision for impairment is recorded against the carrying value of inventories.  The Directors use their knowledge of market conditions to assess future demand for the Group's products and achievable selling prices.

Impairment of goodwill and other intangibles

Determining whether goodwill and other intangibles are impaired requires an estimation of the value in use of the cash-generating units to which goodwill and other intangible assets have been allocated.  The value in use calculation requires estimation of future cash flows expected to arise from the cash-generating unit and a suitable discount rate in order to calculate present value.

Assumptions relating to tax

The Group recognises expected assets for tax based on an estimation of the likely taxes receivable, which requires significant judgment as to the ultimate tax determination of certain items.  Where the actual asset arising from these issues differs from these estimates, such differences will have an impact on income tax and deferred tax assets in the period when such determination is made.

Provisions

Provisions have been made for dilapidations and for closed stores.  The provisions are based on historical experience and management's best knowledge at the time and are reviewed at each balance sheet date.  The actual costs and timing of future cash flows are dependent on future events.  Any difference between expectations and the actual future liability will be accounted for in the period when such determination is made.

 

 

Notes (continued)

2          Segmental reporting

The Directors consider there to be one operating and reportable segment, being that of the sale of pet products and services through retail outlets and the Group's website. 

The Group's Board receives monthly financial information at this level and uses this information to monitor the performance of the store portfolio, allocate resources and make operational decisions.  The internal reporting received focuses on the Group as a whole and does not identify individual segments.  To increase transparency, the Group has decided to include an additional voluntary disclosure analysing revenue within the reportable segments.

 

Revenue

 

 

28 week period ended

9 October 2014

28 week period ended

10 October 2013

52 week period ended

 27 March 2014

 

 

 

 

 

 

 

 

 

£000

£000

£000

 

 

 

 

 

 

Food

 

 

188,743

172,275

327,101

Accessories

 

 

159,582

147,737

288,017

Services and other

 

 

33,196

26,141

50,277

 

 

 

             

             

             

 

 

 

381,521

346,153

665,395

 

 

 

             

             

             

 



 

Notes (continued)

3          Operating profit

The performance of the operating segment is primarily based on a measure of Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) before exceptional items share based payment charges, and management charges (see note 13). This can be reconciled to statutory operating profit as follows:

 

 

 

 

28 week period ended

9 October 2014

28 week period ended

10 October 2013

52 week period ended

27 March 2014

 

 

 

 

 

 

 

 

 

£000

£000

£000

 

 

 

 

 

 

Operating profit

 

 

45,835

41,724

78,842

Exceptional items

 

 

-

-

10,574

Management charges (note 13)

 

 

-

647

1,221

Share based payment charges

 

 

811

-

31

 

 

 

             

             

             

Underlying operating profit

 

 

46,646

42,371

90,668

 

 

 

 

 

 

Depreciation and amortisation

 

 

11,948

10,515

19,990

 

 

 

             

             

             

Underlying Earnings Before Interest, Tax, Depreciation, and Amortisation (EBITDA) (before exceptional items)

 

 

58,594

52,886

110,658

 

 

 

             

             

             

 

Included in profit/loss are the following:

 

 

 

28 week period ended

9 October 2014

28 week period ended

10 October 2013

52 week period ended

27 March 2014

 

 

 

 

 

 

 

 

 

£000

£000

£000

 

 

 

 

 

 

Exceptional operating expenses

 

 

-

-

10,574

Depreciation of tangible fixed assets

 

 

10,773

9,431

18,053

Amortisation of intangible assets

 

 

1,175

1,084

1,937

Rentals under operating leases:

 

 

 

 

 

            Hire of plant and machinery

 

 

1,124

1,598

2,843

            Property

 

 

33,357

32,916

61,903

Rental income from sublets

 

 

(4,056)

(3,067)

(5,952)

Loss on disposal of fixed assets

 

 

-

2

77

 

 

 

             

             

             

Exceptional costs in the 52 week period ended 27 March 2014 related to costs associated with the Initial Public Offering of Pets at Home Group Plc shares on the London Stock Exchange on 17 March 2014 (£9,383,000), and costs associated with the integration of the Vets4Pets business into the group (£2,308,000), offset by a credit relating to exceptional input VAT recovered (£1,117,000).

 

Notes (continued)

4          Earnings per share

Basic earnings per share is calculated by dividing the net profit for the period attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.

 

Diluted earnings per share is calculated by dividing the net profit for the period attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period plus the weighted average number of ordinary shares that would be issued on the conversion of all dilutive potential ordinary shares into ordinary shares.

 

 


28 week period ended

 9 October 2014

28 week period ended

10 October 2013

52 week period ended

27 March 2014








Underlying

After

Exceptionals

Underlying

Underlying

After

Exceptionals








£000

£000

£000

£000

£000







Profit attributable to equity shareholders of the parent

31,549

35,844

15,325

38,565

13,548

Less PEC dividend transferred from retained earnings

-

-

(20,973)

(37,646)

(37,646)


             

             

             

             

             


31,549

35,844

(5,648)

919

(24,098)


             

             

             

             

             








'000s

'000s

'000s

'000s

'000s







Basic weighted average number of shares  

500,000

500,000

165,900

175,054

175,054

Dilutive potential ordinary shares

-

-

-

71

71


             

             

             

             

             

Diluted weighted average number of shares

500,000

500,000

165,900

175,125

175,125


             

             

             

             

             

 

Basic earnings per share

£0.06

£0.07

(£0.03)

£0.01

 

(£0.14)

Diluted earnings per share

£0.06

£0.07

(£0.03)

£0.01

(£0.14)

 

Notes (continued)

5          Financial expense

Recognised in the income statement

 

 

28 week period ended

9 October 2014

28 week period ended

10 October 2013

52 week period ended

27 March 2014

 

 

 

 

 

 

 

£000

£000

£000

 

 

 

 

 

Bank loans at effective interest rate

 

5,545

19,823

36,176

Related party loan notes

 

-

756

1,349

Other interest expense

 

17

27

22

 

 

             

             

             

Total underlying financial expense

 

5,562

20,606

37,547

 

 

 

 

 

Exceptional amortisation costs

 

-

-

19,158

 

 

             

             

             

Total exceptional financial expense

 

-

-

19,158

 

 

             

             

             

Total financial expense

 

5,562

20,606

56,705

 

 

             

             

             

 

Exceptional financial expenses in the 52 week period ended 27 March 2014 related to £19,158,000 of accelerated amortisation following the repayment of the senior bank facility of £567,926,000 in that period.

 

Notes (continued)

6          Taxation

Recognised in the income statement

 

 

 

28 week period ended

9 October

2014

 

 

28 week period

 ended

9 October

2014

28 week period ended

9 October 2014

28 week period ended

10 October 2013

52 week period ended

 27 March 2014

 

 

Underlying

Exceptional

Total

Total

Total

 

 

 

 

 

 

 

 

 

£000

£000

£000

£000

£000

 

Current tax expense

 

 

 

 

 

 

Current period

9,087

-

9,087

4,874

7,840

 

Adjustments in respect of prior periods

-

(4,295)

(4,295)

362

362

 

 

             

             

             

             

             

 

Current tax expense

9,087

(4,295)

4,792

5,236

8,202

 

 

             

             

             

             

             

 

Deferred tax (credit)/expense

 

 

 

 

 

 

Origination and reversal of temporary differences

(171)

-

(171)

219

234

 

Reduction in tax rate

8

-

8

28

28

 

Adjustments in respect of prior periods

-

-

-

493

493

 

 

             

             

             

             

             

 

Deferred tax (credit)expense

(163)

-

(163)

740

755

 

 

             

             

             

             

             

 

Total tax expense

8,924

(4,295)

4,629

5,976

8,957

 

 

             

             

             

             

             

 


 

 

 

 

 

The corporation tax rate applicable to the group was 21% in the period to 9 October 2014. The March 2013 Budget announced that the UK corporation tax rate will further reduce to 20% (effective from 1 April 2015). This reduction was substantively enacted on 2 July 2013. The deferred tax asset has been calculated based on the rate of 20% substantively enacted at the balance sheet date.

Notes (continued)

6          Taxation (continued)

 

Deferred tax recognised in other comprehensive income

 

28 week period ended

9 October 2014

28 week period ended

10 October 2013

52 week period ended

 27 March 2014

 

 

 

 

 

£000

£000

£000

 

 

 

 

Effective portion of changes in fair value of cash flow hedges

197

106

159

 

             

             

             

Reconciliation of effective tax rate

 

 

28 week

period ended

9 October 2014

28 week period ended

9 October 2014

28 week

period ended

9 October 2014

28 week

period ended

10 October 2013

52 week 

period ended

 27 March 2014

 

 

Underlying

Exceptional

Total

Total

Total

 

 

 

 

 

 

 

 

 

£000

£000

£000

£000

£000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the period

31,549

4,295

35,844

15,325

13,548

 

Total tax expense

8,924

(4,295)

4,629

5,976

8,957



             

             

             

             

             

 

Profit excluding taxation

40,473

-

40,473

21,301

22,505



             

             

             

             

             

 

 

 

 

 

 

 

 

Tax using the UK corporation tax rate for the period

8,499

-

8,499

4,899

5,177

 

Impact of reduction in tax rate on deferred tax balances

8

-

8

28

28

 

Expenditure not eligible for tax relief

417

-

417

195

1,094

 

Non-deductible IPO costs - exceptional item

-

-

-

-

2,055

 

Other

-

-

-

-

(251)

 

Adjustments in respect of prior periods

-

(4,295)

(4,295)

854

854



             

             

             

             

             

 

Total tax expense

8,924

(4,295)

4,629

5,976

8,957



             

             

             

             

             

The UK corporation tax standard rate for the period was 21% (period ended 27 March  2014: 23%; period ended 10 October 2013: 23%).

The effective corporation tax rate on pre-exceptional items for the 28 week period ended 9 October 2014 is 22.0% (28 week period ended 28 October 2013: 28.1%) which represents the best estimate of the effective annual corporation tax rate expected for the full year (excluding exceptional items), applied to the pre-tax income for the 28 week period.

The exceptional tax credit of £4.3m in the period represents the release of a provision in respect of interest on debt associated with the pre IPO structure following agreement with HMRC. As part of the IPO process this debt was repaid.

 

 

Notes (continued)

7          Tangible fixed assets

 

Freehold buildings

 

Leasehold improvements

Fixtures, fittings, tools and equipment

Motor vehicles

Total

 

£000

 

£000

£000

£000

£000

Cost

 

 

 

 

 

 

Balance at 28 March 2013

1,444

 

28,598

99,860

9

129,911

Additions

-

 

1,338

8,158

-

9,496

 

             

 

             

             

             

             

Balance at 10 October 2013

1,444

 

29,936

108,018

9

139,407

Additions

1,064

 

4,146

13,104

-

18,314

Disposals

-

 

(1,252)

(19,264)

(9)

(20,525)

 

             

 

             

             

             

             

Balance at 27 March 2014

2,508

 

32,830

101,858

-

137,196

Additions

-

 

926

12,808

-

13,734

Disposals

-

 

-

-

-

-

 

             

 

             

             

             

             

Balance at 9 October 2014

2,508

 

33,756

114,666

-

150,930

 

             

 

             

             

             

             

Depreciation

 

 

 

 

 

 

Balance at 28 March 2013

49

 

6,144

39,096

-

45,289

Depreciation charge for the period

16

 

1,321

8,094

-

9,431

Disposals

 

-

-

-

-

-

 

             

 

             

             

             

             

Balance at 10 October 2013

65

 

7,465

47,190

-

54,720

Depreciation charge the period

14

 

1,133

7,475

-

8,622

Disposals

-

 

(618)

(19,156)

-

(19,774)

 

             

 

             

             

             

             

Balance at 27 March 2014

79

 

7,980

35,509

-

43,568

Depreciation charge the period

111

 

1,197

9,465

-

10,773

Disposals

-

 

-

-

-

-

 

             

 

             

             

             

             

Balance at 9 October 2014

190

 

9,177

44,974

-

54,341

 

             

 

             

             

             

             

 

 

 

 

 

 

 

Net book value

 

 

 

 

 

 

At 28 March 2013

1,395

 

22,454

60,764

9

84,622

At 10 October 2013

1,379

 

22,471

60,828

9

84,687

At 27 March 2014

2,429

 

24,850

66,349

-

93,628

At 9 October 2014

2,318

 

24,579

69,692

-

96,589

 

             

 

             

             

             

             

 

8          Intangible assets

 

Goodwill

Software

Total

 

£000

£000

£000

Cost

 

 

 

Balance at 28 March 2013

952,032

6,174

958,206

Additions

-

1,376

1,376

 

             

             

             

Balance at 10 October 2013

952,032

7,550

959,582

Additions

-

795

795

 

             

             

             

Balance at 27 March 2014

952,032

8,345

960,377

Additions

-

957

957

 

             

             

             

Balance at 9 October 2014

952,032

9,302

961,334

 

             

             

             

Amortisation

 

 

 

Balance at 28 March 2013

-

3,202

3,202

Amortisation for the period

-

1,084

1,084

 

             

             

             

Balance at 10 October 2013

-

4,286

4,286

Amortisation for the period

-

853

853

 

             

             

             

Balance at 27 March 2014

-

5,139

5,139

Amortisation for the period

-

1,175

1,175

 

             

             

             

Balance at 9 October 2014

-

6,314

6,314

 

             

             

             

 

Net book value

 

 

 

At 28 March 2013

952,032

2,972

955,004

At 10 October 2013

952,032

3,264

955,296

At 27 March 2014

952,032

3,206

955,238

 

             

             

             

At 9 October 2014

952,032

2,988

955,020

 

             

             

             

 

Notes (continued)

8      Intangible assets (continued)

Amortisation and impairment charge

The amortisation charge is recognised in total in operating expenses within the income statement.

Impairment testing

Cash Generating Units ('CGU') within the group are considered to be the body of stores and website as disclosed in note 2. The Group is deemed to have one overall group of CGUs as follows:

 

 

Goodwill

At 9 October 2014

At 10 October 2013

At 27 March 2014

 

£000

£000

£000

 

 

 

 

Pets at Home Group

        952,032

952,032

952,032

The recoverable amount of the CGU group has been calculated with reference to its value in use.  The key assumptions of this calculation are shown below:

 

At 9 October 2014

At 10 October 2013

At 27 March 2014

 

£000

£000

£000

 

 

 

 

Period on which management approved forecasts are based (years)

3

3

3

Growth rate applied beyond approved forecast period

3%

3%

3%

Discount rate (pre-tax)

8%

8%

9%

 

 

 

 

The goodwill is considered to have an indefinite useful life and the recoverable amount is determined based on "value-in-use" calculations.  These calculations use pre-tax cash flow projections based on a 3 year business plan approved by the Board.  These projections are based on all available information and growth rates do not exceed growth rates achieved in prior periods.

The discount rate was estimated based on past experience and industry average weighted average cost of capital.  Management have assumed a growth rate projection beyond the 3 year period based on inflationary increases. Sensitivity analysis was performed with a 2% movement in the discount rate with no indicators of impairment identified.

The total recoverable amount in respect of goodwill for the CGU group as assessed by the managers using the above assumptions is greater than the carrying amount and therefore no impairment charge has been booked in each period.  The Directors consider that it is not reasonably possible for the assumptions to change so significantly as to eliminate the excess.

 

 

Notes (continued)

9          Other interest-bearing loans and borrowings

 

 

 

 

 

 

 

 

 

 

 

 

At 9 October 2014

At 10 October 2013

At 27 March 2014

 

 

 

 

 

£000

£000

£000

Non-current liabilities

 

 

 

Secured bank loans

315,420

534,196

319,855

 

             

             

             

Current liabilities

 

 

 

Current portion of secured bank loans

5,000

12,408

-

 

             

             

             

Total liabilities

 

 

 

Secured bank loans

320,420

546,604

319,855

 

             

             

             

Terms and debt repayment schedule


Nominal interest rate

Year of

maturity

 

Face

value

Carrying amount

 

Face

value

Carrying amount

 

Face

value

Carrying amount













9 October 2014

9 October 2014

10 October 2013

10 October 2013

27 March 2014

27 March 2014 













£000

£000

£000

£000

£000

£000










Senior Bank Loans

LIBOR +3-5%

2018

-

-

567,926

546,604

-

-

Senior Finance Bank Loans

LIBOR +2-2.25%

2019/20

325,000

320,420

-

-

325,000

319,855




                 

               

                 

               

                 

               




325,000

320,420

567,926

546,604

325,000

319,855




                 

               

                 

               

             

             

 

 

 

 

 

 

 

 

 

The Group has a revolving credit facility of £30m of which £29.6m was undrawn at the period end (period ended 28 March 2014 £29.6m). The revolving credit facility is available for drawing to and including 16 February 2018 and will terminate on 17 March 2019.

All bank borrowings are secured by fixed and floating charges over substantially all of the assets of the Pets at Home Group Plc and certain of its subsidiaries. The security includes fixed charges over the head office freehold property, the distribution centre leasehold properties, and any plant and machinery owned by the Company or the relevant subsidiaries. The senior bank loans bear interest at LIBOR plus a margin, currently varying between 2.0% and 2.25%, with the margin decreasing as the Group's leverage (defined as total net debt to consolidated EBITDA) decreases. The senior bank loans are due for repayment at various dates up to 17 March 2020.

 

Notes (continued)

9      Other interest-bearing loans and borrowings (continued)

On 17 March 2014 the business repaid the senior finance bank loans replacing them with a new senior finance facility, which has significantly reduced the interest charge of the Group. The new senior bank facility was drawn down on 17 March 2014. The new senior bank facility is held by the company.

Pets at Home Group Plc has entered into fixed rate interest rate swap agreements over a total of £243.5m of the senior facility borrowings at a fixed rate of 0.74% and a further fixed rate interest rate swap over a total of £73.3m at a fixed rate of 0.655% (period ended 27 March 2014: £299.1m of the senior facility borrowings at a fixed rate of 0.74% and £17.7m at a fixed rate of 0.655%; period ended 10 October 2013: £303.4m of the senior facility borrowings at a fixed rate of 0.74% and £98.4m at a fixed rate of 0.655%).  Both swaps expire on 30 March 2016.  The hedges are structured to hedge at least 70% of the outstanding debt.   

The analysis of repayments on the combined loan principal is as follows:

 

 

At 9 October 2014

At 10 October 2013

At 27 March 2014

 

 

 

 

 

£000

£000

£000

 

 

 

 

Within one year or repayable on demand

5,000

12,408

-

Between one and two years

12,500

17,512

5,000

Between two and five years

72,500

403,006

85,000

After five years

235,000

135,000

235,000

 

             

             

             

 

325,000

567,926

325,000

 

             

             

             


 

Notes (continued)

10        Financial instruments

Fair value hierarchy

The table below analyses financial instruments measured at fair value, into a fair value hierarchy based on the valuation technique used to determine fair value.

§  Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities.

§  Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices).

§  Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

 

9 October 2014

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

£000

£000

£000

£000

 

 

 

 

 

Available for sale financial assets

 

 

 

 

Investment in equity securities

-

-

7,230

7,230

 

 

 

 

 

Derivative financial assets

 

 

 

 

Interest rate swaps

-

191

-

191

Forward rate contracts

-

344

-

344

 

 

 

 

 

 

 

10 October 2013

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

£000

£000

£000

£000

 

 

 

 

 

Available for sale financial assets

 

 

 

 

Investment in equity securities

-

-

4,610

4,610

 

 

 

 

 

Derivative financial assets

 

 

 

 

Interest rate swaps

-

194

-

194

 

 

 

 

 

Derivative financial liabilities

 

 

 

 

Forward rate contracts

-

(747)

-

(747)

 

 

27 March 2014

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

£000

£000

£000

£000

 

 

 

 

 

Available for sale financial assets

 

 

 

 

Investment in equity securities

-

-

5,957

5,957

 

 

 

 

 

Derivative financial assets

 

 

 

 

Interest rate swaps

-

662

-

662

 

 

 

 

 

Derivative financial liabilities

 

 

 

 

Forward rate contracts

-

(1,113)

-

(1,113)

 


 

Notes (continued)

10        Financial instruments (continued)

Measurement of fair values

 

Valuation techniques and significant unobservable inputs

 

The following table shows the valuation techniques used in measuring Level 2 and Level 3 fair values at the balance sheet dates, as well as the significant unobservable inputs used.

 

Type

Valuation technique

Significant unobservable inputs

Inter-relationship between significant unobservable inputs and fair value measurement

 

 

 

 

 

 

 

 

Investment in equity securities

The fair value of investments in unlisted equity securities are considered to be their carrying value as the impact of discounting future cash flows has been assessed as not material and the investment is non-participatory.

Not applicable

Not applicable

 

 

 

 

Forward exchange contracts and interest rate swaps

Market comparison technique - the fair values are based on broker quotes. Similar contracts are traded in an active market and the quotes reflect the actual transactions on similar instruments.

Not applicable

Not applicable

 

11        Dividends

On 3 December 2014 the directors declared an interim dividend of 1.8 pence per share, amounting to £9.0 million, which is payable on 16 January 2015 to ordinary shareholders on the register at the close of business on 12 December 2014.

12        Seasonality of operations

The Group's sales can be sensitive to periods of extreme weather conditions. The Group sometimes sees a reduction in sales during periods of hot weather in the UK, due to reduced customer footfall and reduced demand as pets eat less and generally spend more time outdoors, reducing the need for essentials such as food and cat litter. If temperatures are extremely high for a prolonged period, declines in sales can be material. The number of customers visiting Pets at Home's stores also declines during periods of snow or extreme weather conditions affecting the local catchment area. In addition, the sales of certain products and services designed to address pet health needs, such as flea and tick problems, can also be seasonal, increasing in times of warm and wet weather.

Traditionally the financial performance of the Group in the four-week period to the end of December is marginally stronger than in the other periods, due to Christmas purchasing. Purchasing of Accessories is also more prevalent during this season. Timing of the holiday season and any adverse weather conditions that may occur during that season impacting delivery may adversely affect sales in Pets at Home stores.



 

Notes (continued)

 

13        Related party transactions

Management fees

Kohlberg Kravis Roberts & Co. L.P. received management fees of £nil (period to 27 March 2014 £1,221,000; period to 10 October 2013 £647,000), which includes the provision of non-executive director services and expenses recharged. 

Kohlberg Kravis Roberts & Co. L.P. also received fees of £nil and expenses of £nil (period to 27 March 2014 fees of £8,685,105 and expenses of £113,735; period to 10 October 2013 fees of £nil and expenses of £nil), relating to a termination payment and transaction fees following the termination of the advisory services agreement dated 19 March 2010 upon admission of the Pets at Home Group to the premium listing segment of the Official List and to the London Stock Exchange on 17 March 2014.

KKR Capital Markets LLC received fees of £nil (period to 27 March 2014 and period to 10 October 2013 £600,000), relating to professional services associated with debt financing following the refinancing of the Pets at Home Group in April 2013, £nil (period to 27 March 2014 £1,775,000; period to 10 October 2013 £nil) relating to professional services associated with the debt refinancing of the Pets at Home Group in March 2014, £nil (period to 27 March 2014 £1,757,307; period to 10 October 2013 £nil) relating to fees in relation to the Pets at Home Group Plc IPO, and £nil (period to 27 March 2014 £200,000; period to 10 October 2013 £nil)  relating to professional services associated with the arrangement of loan agreements which Companion Care Management Services Limited became party to in March 2014.

The additional paid in capital of PAH Lux S.a.r.l. represented a related party transaction with investors in the Group prior to the reorganisation as described in note 1 to the financial statements for the period ended 27 March 2014.

Veterinary practice transactions                                                                                                                     

The Group has entered into a number of arrangements with third parties in respect of veterinary practices.  These veterinary practices are deemed to be related parties.

The transactions entered into during the period, and the balances outstanding at the end of the period are as follows:

 

 

28 week period ended 9 October 2014

28 week period ended 10 October 2013

52 week period ended  27 March 2014

 

 

 

 

 

£000

£000

£000

Transactions

 

 

 

Fees for services provided to veterinary practices

14,832

11,371

21,610

Rental charges to veterinary practices

3,525

2,559

5,039

 

             

             

             

 

At 9 October 2014

At 10 October 2013

At 27 March 2014

 

 

 

 

 

£000

£000

£000

Balances      

 

 

 

Due from veterinary practice companies at end of period included within other receivables

9,247

7,518

12,673

 

             

             

             

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR UOOBRSUAURAA
UK 100

Latest directors dealings